Juan Xu

6.1k total citations · 1 hit paper
144 papers, 3.7k citations indexed

About

Juan Xu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Juan Xu has authored 144 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 67 papers in Cancer Research and 17 papers in Immunology. Recurrent topics in Juan Xu's work include Cancer-related molecular mechanisms research (49 papers), RNA modifications and cancer (48 papers) and RNA Research and Splicing (38 papers). Juan Xu is often cited by papers focused on Cancer-related molecular mechanisms research (49 papers), RNA modifications and cancer (48 papers) and RNA Research and Splicing (38 papers). Juan Xu collaborates with scholars based in China, United States and United Kingdom. Juan Xu's co-authors include Xia Li, Yongsheng Li, Tingting Shao, Zheng Zhao, Zishan Wang, Junyi Li, Hong Chen, Jing Bai, Na Ding and Tao Pan and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

In The Last Decade

Juan Xu

136 papers receiving 3.6k citations

Hit Papers

Pan-cancer characterizati... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan Xu China 31 2.8k 2.3k 277 274 210 144 3.7k
Peng Gao China 30 2.3k 0.8× 1.8k 0.8× 277 1.0× 425 1.6× 232 1.1× 151 3.1k
Guang‐Rong Yan China 26 2.7k 0.9× 1.5k 0.6× 271 1.0× 534 1.9× 433 2.1× 45 3.6k
Yu‐Shui Ma China 31 1.9k 0.7× 1.3k 0.6× 339 1.2× 619 2.3× 332 1.6× 117 3.0k
Liang‐Chuan Lai Taiwan 30 2.4k 0.8× 1.0k 0.4× 343 1.2× 386 1.4× 252 1.2× 146 3.4k
Honghe Zhang China 32 2.1k 0.7× 1.7k 0.7× 406 1.5× 716 2.6× 311 1.5× 91 3.4k
Alfredo Hidalgo‐Miranda Mexico 30 1.9k 0.7× 1.4k 0.6× 218 0.8× 561 2.0× 320 1.5× 104 3.1k
Miao He China 37 2.1k 0.8× 1.3k 0.6× 439 1.6× 904 3.3× 339 1.6× 117 3.4k
Wei Gao China 31 1.7k 0.6× 979 0.4× 202 0.7× 419 1.5× 197 0.9× 124 2.5k
Shuang G. Zhao United States 28 2.8k 1.0× 2.7k 1.2× 1.0k 3.7× 530 1.9× 186 0.9× 98 4.4k

Countries citing papers authored by Juan Xu

Since Specialization
Citations

This map shows the geographic impact of Juan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Xu more than expected).

Fields of papers citing papers by Juan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Xu. The network helps show where Juan Xu may publish in the future.

Co-authorship network of co-authors of Juan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Xu. A scholar is included among the top collaborators of Juan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Xu. Juan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Ma, Yingying, et al.. (2025). Enhancer RNA–mediated transcriptional regulatory programs reveal the malignant progression of glioma. Science Advances. 11(23). eadu9487–eadu9487. 1 indexed citations
4.
Qin, Haotian, Juan Xu, Meiling Chen, et al.. (2025). Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC. Frontiers in Immunology. 15. 1456649–1456649. 5 indexed citations
5.
Zhou, Weiwei, Jingyi Shi, Yueying Gao, et al.. (2025). SMTdb: A Comprehensive Spatial Meta-Transcriptome Resource in Cancer. Molecular Biology and Evolution. 42(11).
6.
Ma, Yingying, Jiaxin Yang, Jiaxin Yu, et al.. (2025). Multi-omics-guided characterization of neoantigens improves patient stratification and potentiates combinatorial immunotherapy in glioma. Cell Reports. 44(12). 116704–116704.
7.
Zhang, Ying, et al.. (2025). Intricating connections: the role of ferroptosis in systemic lupus erythematosus. Frontiers in Immunology. 16. 1534926–1534926. 2 indexed citations
8.
Zhou, Weiwei, Tiantongfei Jiang, Yingying Ma, et al.. (2024). Cancer Stemness Online: A Resource for Investigating Cancer Stemness and Associations with Immune Response. Genomics Proteomics & Bioinformatics. 22(4). 1 indexed citations
9.
Jiang, Yanan, et al.. (2023). An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications. Cell Death Discovery. 9(1). 266–266. 29 indexed citations
10.
Zhou, Weiwei, Tiantongfei Jiang, Kang Xu, et al.. (2023). SORC: an integrated spatial omics resource in cancer. Nucleic Acids Research. 52(D1). D1429–D1437. 18 indexed citations
11.
Jiang, Tiantongfei, Weiwei Zhou, Jiaxin Yu, et al.. (2022). ImmCluster: an ensemble resource for immunology cell type clustering and annotations in normal and cancerous tissues. Nucleic Acids Research. 51(D1). D1325–D1332. 9 indexed citations
12.
Clare, Connie, Valerie Pestinger, Wing Yee Kwong, et al.. (2021). Interspecific Variation in One-Carbon Metabolism within the Ovarian Follicle, Oocyte, and Preimplantation Embryo: Consequences for Epigenetic Programming of DNA Methylation. International Journal of Molecular Sciences. 22(4). 1838–1838. 26 indexed citations
13.
Li, Chunxue, Juan Xu, Xiangfeng Wang, et al.. (2021). Whole exome and transcriptome sequencing reveal clonal evolution and exhibit immune-related features in metastatic colorectal tumors. Cell Death Discovery. 7(1). 222–222. 15 indexed citations
14.
Xu, Kang, Xiyun Jin, Junyi Li, et al.. (2020). LncSpA: LncRNA Spatial Atlas of Expression across Normal and Cancer Tissues. Cancer Research. 80(10). 2067–2071. 42 indexed citations
15.
Li, Xia, Juan Xu, Yun Xiao, Shangwei Ning, & Yunpeng Zhang. (2018). Non-coding RNAs in Complex Diseases : A Bioinformatics Perspective. Springer eBooks. 3 indexed citations
16.
Li, Yongsheng, et al.. (2018). Computational Identification of Cross-Talking ceRNAs. Advances in experimental medicine and biology. 1094. 97–108. 36 indexed citations
17.
Tang, Yaping, Tao Yang, Juan Xu, et al.. (2017). Fruit characteristic and flesh tissue feature of special firmness type processing tomato cultivar.. Nongye gongcheng xuebao. 33(18). 285–290. 2 indexed citations
18.
Xu, Juan, Yongsheng Li, Xiang Li, et al.. (2012). Dissection of the potential characteristic of miRNA–miRNA functional synergistic regulations. Molecular BioSystems. 9(2). 217–224. 20 indexed citations
19.
Liu, Shuzhen, Jingwen Han, Ze Yun, et al.. (2012). Changes of Polar Metabolites in Guoqing No.1 Satsuma Mandarine During Fruit Ripening. 45(21). 4437–4446. 2 indexed citations
20.
Xu, Juan, Chuanxing Li, Yun Xiao, et al.. (2011). Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer. Molecular Cancer Therapeutics. 10(10). 1857–1866. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026